Literature DB >> 10797384

Antigenic properties and diagnostic potential of recombinant dobrava virus nucleocapsid protein.

H Kallio-Kokko1, A Lundkvist, A Plyusnin, T Avsic-Zupanc, A Vaheri, O Vapalahti.   

Abstract

Dobrava hantavirus (DOBV) causes severe hemorrhagic fever with renal syndrome in the Balkan region and has been detected recently also in Russia, Estonia, and Germany. DOBV nucleocapsid protein (N) was produced in insect cells, using the baculovirus expression system (bac-DOBV-N), and in E. coli as a truncated (aa 1-165) glutathione-S transferase fusion protein (DOBV-dN-GST). The antigenic properties of bac-DOBV-N were found identical to native DOBV-N when examined by a panel of hantavirus-specific monoclonal antibodies. Enzyme immunoassays for detection of IgM and IgG antibodies were set up using DOBV recombinant N proteins and compared with those based on recombinant Hantaan and Puumala virus N, using panels of sera collected from DOBV, Hantaan and Puumala virus-infected patients. Full-length N protein (bac-DOBV-N) was found to be a more sensitive antigen than DOBV-dN-GST. The sensitivity values for sera from DOBV-infected patients were 100% for bac-DOBV-N and 86% for DOBV-dN-GST by IgM assays, and 98% for bac-DOBV-N and 88% for DOBV-dN-GST by IgG assays. The specificity values were 100% for bac-DOBV-N and 99% for DOBV-dN-GST by IgM assays, and 100% for both antigens by IgG assays. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797384

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy.

Authors:  H Kallio-Kokko; J Laakkonen; A Rizzoli; V Tagliapietra; I Cattadori; S E Perkins; P J Hudson; A Cristofolini; W Versini; O Vapalahti; A Vaheri; H Henttonen
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

Review 4.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections.

Authors:  K Araki; K Yoshimatsu; M Ogino; H Ebihara; H Kariwa; I Takashima; J Arikawa
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 6.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

Review 7.  Hantaviruses: an emerging public health threat in India? A review.

Authors:  S Chandy; S Abraham; G Sridharan
Journal:  J Biosci       Date:  2008-11       Impact factor: 2.795

8.  The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.

Authors:  Aurelija Zvirbliene; Indre Kucinskaite-Kodze; Ausra Razanskiene; Rasa Petraityte-Burneikiene; Boris Klempa; Rainer G Ulrich; Alma Gedvilaite
Journal:  Viruses       Date:  2014-02-07       Impact factor: 5.048

Review 9.  Hantavirus Induced Kidney Disease.

Authors:  Sheema Mir
Journal:  Front Med (Lausanne)       Date:  2022-01-18

Review 10.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.